UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.777

Sortiert nach

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Intensive care medicine, 2023-02, Vol.49 (2), p.178-190

2023

Volltextzugriff (PDF)

Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae

Intensive care medicine, 2018-05, Vol.44 (5), p.616-626

2018

Volltextzugriff (PDF)

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2021-04, Vol.72 (7), p.1109-1116

2021

Volltextzugriff (PDF)

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2021-04, Vol.72 (7), p.e169-e183

2021

Volltextzugriff (PDF)

A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

The Lancet (British edition), 2018-09, Vol.392 (10150), p.821-834

2018

Volltextzugriff (PDF)

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2022-08, Vol.75 (2), p.187-212

2022

Volltextzugriff (PDF)

Carbapenemase-Producing Organisms: A Global Scourge

Clinical infectious diseases, 2018-04, Vol.66 (8), p.1290-1297

2018

Volltextzugriff (PDF)

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

Carbapenems: Past, Present, and Future

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.4943-4960

2011

Volltextzugriff (PDF)

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Clinical infectious diseases, 2016-09, Vol.63 (6), p.754-762

2016

Volltextzugriff (PDF)

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Volltextzugriff (PDF)

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

Clinical infectious diseases, 2022-07, Vol.74 (12), p.2089-2114

2022

Volltextzugriff (PDF)

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

The European respiratory journal, 2017-05, Vol.49 (5), p.1700387-1700387

2017

Volltextzugriff (PDF)

Deaths attributable to carbapenem-resistant Enterobacteriaceae infections

Emerging infectious diseases, 2014-07, Vol.20 (7), p.1170-1175

2014

Volltextzugriff (PDF)

Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA

Clinical infectious diseases, 2022-03, Vol.74 (5), p.905-908

2022

Volltextzugriff (PDF)

Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

Antimicrobial agents and chemotherapy, 2014-04, Vol.58 (4), p.2322-2328

2014

Volltextzugriff (PDF)

Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)

Clinical infectious diseases, 2023-06, Vol.76 (12), p.2059-2069

2023

Volltextzugriff (PDF)

New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams

International journal of molecular sciences, 2020-12, Vol.21 (23), p.9308

2020

Volltextzugriff (PDF)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria

Frontiers in cellular and infection microbiology, 2022-03, Vol.12, p.823684-823684

2022

Volltextzugriff (PDF)

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia

Clinical infectious diseases, 2017-02, Vol.64 (3), p.257-264

2017

Volltextzugriff (PDF)

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Clinical infectious diseases, 2019-08, Vol.69 (5), p.769-776

2019

Volltextzugriff (PDF)

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

Clinical infectious diseases, 2015-05, Vol.60 (9), p.1295-1303

2015

Volltextzugriff (PDF)

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality

Clinical infectious diseases, 2017-03, Vol.64 (6), p.711-718

2017

Volltextzugriff (PDF)

Integrated chromosomal and plasmid sequence analyses reveal diverse modes of carbapenemase gene spread among Klebsiella pneumoniae

Proceedings of the National Academy of Sciences - PNAS, 2020-10, Vol.117 (40), p.25043-25054

2020

Volltextzugriff (PDF)

1 – 25 von 2.777

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.605)
Mit Volltextzugriff
(2.331)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.601)
Science & Technology
(2.359)
Life Sciences & Biomedicine
(2.269)
Anti-Bacterial Agents - Therapeutic Use
(2.179)
Carbapenems - Therapeutic Use
(1.642)
Infectious Diseases
(1.318)
Microbiology
(1.101)
Anti-Bacterial Agents - Pharmacology
(1.093)
Microbial Sensitivity Tests
(1.061)
Carbapenems - Pharmacology
(977)
Male
(926)
Female
(906)
Carbapenems
(803)
Pharmacology & Pharmacy
(745)
Antibiotics
(695)
Middle Aged
(690)
Aged
(640)
Adult
(575)
Retrospective Studies
(567)
Klebsiella Pneumoniae
(442)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Carbapenemase-Producing Organisms: A Global Scourge

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Carbapenems: Past, Present, and Future

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Deaths attributable to carbapenem-resistant Enterobacteriaceae infections

Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA

Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)

New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality

Integrated chromosomal and plasmid sequence analyses reveal diverse modes of carbapenemase gene spread among Klebsiella pneumoniae

Suchergebnisse filtern